loadpatents
name:-0.02819299697876
name:-0.0069410800933838
name:-0.0032730102539062
Skegro; Darko Patent Filings

Skegro; Darko

Patent Applications and Registrations

Patent applications and USPTO patent grants for Skegro; Darko.The latest application filed is for "production of t cell retargeting hetero-dimeric immunoglobulins".

Company Profile
3.10.27
  • Skegro; Darko - Grenchen CH
  • SKEGRO; Darko - La Chaux-de-Fonds CH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fc variant antibodies and their uses
Grant 11,267,891 - Blein , et al. March 8, 2
2022-03-08
Production Of T Cell Retargeting Hetero-dimeric Immunoglobulins
App 20210171661 - BLEIN; Stanislas ;   et al.
2021-06-10
Trispecific Binding Molecules Against Tumor-associated Antigents And Use Thereof
App 20200362054 - GRANDA; Brian ;   et al.
2020-11-19
Antibodies That Bind To Tl1a And Their Uses
App 20200079863 - ATTINGER; Antoine ;   et al.
2020-03-12
Hetero-Dimeric Immunoglobulins
App 20200024367 - BLEIN; Stanislas ;   et al.
2020-01-23
Engineered Heterodimeric Proteins
App 20190382475 - CEBE; Regis ;   et al.
2019-12-19
Cd3/cd38 T Cell Retargeting Hetero-dimeric Immunoglobulins And Methods Of Their Production
App 20190135918 - OLLIER; Romain ;   et al.
2019-05-09
Production Of T Cell Retargeting Hetero-dimeric Immunoglobulins
App 20180355064 - BLEIN; Stanislas ;   et al.
2018-12-13
Hetero-Dimeric Immunoglobulins
App 20180094077 - BLEIN; Stanislas ;   et al.
2018-04-05
Antibodies That Bind To Tl1a And Their Uses
App 20180086840 - ATTINGER; Antoine ;   et al.
2018-03-29
Anti-trka Antibodies With Enhanced Inhibitory Properties And Derivatives Thereof
App 20170218087 - BLEIN; Stanislas ;   et al.
2017-08-03
Hetero-dimeric immunoglobulins
Grant 9,683,053 - Blein , et al. June 20, 2
2017-06-20
Hetero-dimeric immunoglobulins
Grant 9,683,052 - Blein , et al. June 20, 2
2017-06-20
Production of T cell retargeting hetero-dimeric immunoglobulins
App 20170145115 - BLEIN; Stanislas ;   et al.
2017-05-25
Production of T cell retargeting hetero-dimeric immunoglobulins
Grant 9,493,563 - Blein , et al. November 15, 2
2016-11-15
Anti-trka Antibodies With Enhanced Inhibitory Properties And Derivatives Thereof
App 20160319027 - BLEIN; Stanislas ;   et al.
2016-11-03
Antibodies that bind to TL1A and their uses
Grant 9,290,576 - Attinger , et al. March 22, 2
2016-03-22
Anti-alpha2 Integrin Antibodies And Their Uses
App 20150232559 - Blein; Stanislas ;   et al.
2015-08-20
Anti-trka Antibodies With Enhanced Inhibitory Properties And Derivatives Thereof
App 20150183885 - BLEIN; Stanislas ;   et al.
2015-07-02
Production of T cell retargeting hetero-dimeric immunoglobulins
App 20150133640 - BLEIN; Stanislas ;   et al.
2015-05-14
Anti-alpha2 integrin antibodies and their uses
Grant 8,975,376 - Blein , et al. March 10, 2
2015-03-10
Antibodies That Bind To Tl1a And Their Uses
App 20140308271 - ATTINGER; ANTOINE ;   et al.
2014-10-16
Humanized Antibodies That Bind To Cd19 And Their Uses
App 20140286934 - BLEIN; Stanislas ;   et al.
2014-09-25
Hetero-Dimeric Immunoglobulins
App 20140187753 - Blein; Stanislas ;   et al.
2014-07-03
Humanized antibodies that bind to CD19 and their uses
Grant 8,679,492 - Blein , et al. March 25, 2
2014-03-25
Hetero-Dimeric Immunoglobulins
App 20140066599 - Blein; Stanislas ;   et al.
2014-03-06
Anti-trka Antibodies With Enhanced Inhibitory Properties And Derivatives Thereof
App 20130344064 - BLEIN; STANISLAS ;   et al.
2013-12-26
Hetero-Dimeric Immunoglobulins
App 20130178605 - Blein; Stanislas ;   et al.
2013-07-11
Anti-alpha2 Integrin Antibodies And Their Uses
App 20130052191 - Blein; Stanislas ;   et al.
2013-02-28
Humanized antibodies that bind to CD19 and their uses
App 20100215651 - BLEIN; STANISLAS ;   et al.
2010-08-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed